Evidence map›Paper›PMID 41516201›Full record

ReviewInternational journal of molecular sciences2025

Multifaceted Roles of IL-26 in Physiological and Pathological Conditions.

Boryana Georgieva, Danijela Karanović, Ivona Veličković, Danail Minchev

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Interleukin-24 in type 2 immune diseases.Frontiers in immunology · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Boryana GeorgievaDepartment of Human Anatomy and Physiology, Faculty of Biology, Paisii Hilendarski University of Plovdiv, 24 Tsar Assen St, 4000 Plovdiv, Bulgaria.
Danijela KaranovićInstitute for Medical Research, National Institute of Republic of Serbia, University of Belgrade, Dr Subotića 4, 11000 Belgrade, Serbia.ORCID 0000-0001-5746-746X
Ivona VeličkovićInstitute of Botany and Botanical Garden "Jevremovac", University of Belgrade-Faculty of Biology, 11000 Belgrade, Serbia.
Danail MinchevDepartment of Human Anatomy and Physiology, Faculty of Biology, Paisii Hilendarski University of Plovdiv, 24 Tsar Assen St, 4000 Plovdiv, Bulgaria.

Funding

European Union-NextGenerationEU, through the National Recovery and Resilience Plan of the Republic of Bulgaria BG-RRP-2.004-0001-C01
6 · The paper itself

Abstract

Cytokines are a diverse group of signaling proteins that regulate immune responses by mediating cell communication. Among them, interleukins (ILs) play essential roles in immune regulation, influencing diverse cell processes through tightly controlled signaling networks. Dysregulation of interleukin signaling could lead to chronic inflammation, contributing to the development of autoimmune and inflammatory diseases as well as cancer. IL-26, a cytokine of the IL-10 family, has emerged as a unique modulator of immune function. Although structurally related to IL-10 and sharing one of its receptor subunits, IL-26 exerts distinct biological effects, particularly in promoting inflammatory responses and interacting with extracellular DNA to activate immune pathways. Increasing evidence implicates IL-26 in the development of several chronic conditions, such as psoriasis, rheumatoid arthritis, inflammatory bowel disease, asthma, and various types of cancer. This review summarizes current knowledge on IL-26's biology, including its structural and receptor characteristics, immunomodulatory functions, and roles in inflammation and disease. Understanding IL-26's dual functions in normal and inflammatory states may provide insights into novel therapeutic strategies targeting IL-26-mediated pathways in pathological conditions.

Indexed as

InterleukinsAnimalsAutoimmune DiseasesHumansInflammationNeoplasmsSignal TransductionIL26 protein, humanInterleukinsantimicrobial activitycancerIL-26inflammation

Identifiers

PMID41516201
PMCPMC12785554

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.